The clinical use of the colon cancer vaccine began in Russia.
Patients are now being recruited, said Igor Borisevich, deputy head of the Federal Agency for Medicine and Biology.
According to him, Oncopt's mRNA vaccine was created on the basis of neo-antigens of cancer cells in a specific sick person. A representative of the FMBA spoke about this at the Congress session "Innovative Practice: Science plus Business".